GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Essential Autolysin Activity in Gram-positive Bacteria

$271,700
Hendrik Szurmant · Western University Of Health Sciences · R01 · FY2017 · GM

Complement mediated lysis resistance genes of Leishmania

$271,608
Jeffrey K Beetham · Iowa State University · R01 · FY2008 · AI

The rectal microbiome and incident rectal sexually transmitted infections

$271,600
Susan Anne Tuddenham · Johns Hopkins University · R21 · FY2021 · AI

Training in Geographic Medicine and Infectious Diseases

$271,573
James Walter Kazura · Case Western Reserve University · T32 · FY2011 · AI

Retrocyclins: Circular Defensins Active Against HIV-1

$271,559
University Of Central Florida · R01 · FY2003 · AI

STRUCTURE/FUNCTION RELATIONSHIPS OF HPPK

$271,374
Michigan State University · R01 · FY2001 · GM

Pediatric Infectious Diseases Research Training

$271,324
Michael R Wessels · Boston Children'S Hospital · T32 · FY2012 · HD

Metallobiochemistry of innate immunity and bacterial physiology

$271,261
Elizabeth M Nolan · Massachusetts Institute Of Technology · R01 · FY2020 · GM

Enzymology of Antibiotic Resistance

$271,250
Richard N Armstrong · Vanderbilt University · R56 · FY2009 · AI

Bacterial biofilms in otitis media

$271,080
William E Swords · Wake Forest University Health Sciences · R01 · FY2009 · DC

Bacterial biofilms in otitis media

$271,080
William E Swords · Wake Forest University Health Sciences · R01 · FY2008 · DC

Innate Immunity in Acne Vulgaris

$271,040
Jenny J Kim · University Of California Los Angeles · R01 · FY2009 · AR

Transition-State Analogue Inhibitors of Dihydrofolate Synthetase for MDR/XDR TB

$271,034
John A Zebala · Syntrix Biosystems, Inc. · R43 · FY2011 · AI

Investigation of a shipworm endosymbiont compound with activity against the AIDS-associated pathogens Cryptosporidium and Toxoplasma

$270,988
Roberta M O'Connor · Tufts Medical Center · R21 · FY2016 · AT

The Role of MKP-1 in innate immune responses to LPS

$270,962
Yusen Liu · Research Inst Nationwide Children'S Hosp · R01 · FY2010 · AI

Treat-to-target and personalized approach to periodontal therapy

$270,669
Efthimia Ioannidou · University Of Connecticut Sch Of Med/Dnt · R34 · FY2018 · DE

Vaccine and Treatment Evaluation Units: Concept and Protocol Development, Implementation and Assays

$270,634
Hana El Sahly · Baylor College Of Medicine · N01 · FY2020 · AI

Mechanism of the Usher in Assembly and Secretion of Pili

$270,576
David G Thanassi · State University New York Stony Brook · R01 · FY2010 · GM

Dental prescribing of antibiotics and opioids: high use in the absence of evidence

$270,549
Kj Suda · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · HS

Bioagent Characterization by Iterative Extension

$270,540
Richard Ashley Hurt · Atom Sciences, Inc. · R43 · FY2007 · AI

Defense of oral epithelial cells from candida by hBDs

$270,375
Case Western Reserve University · R01 · FY2005 · DE

Spin-Labeled Peptide Antibiotics

$270,297
Medical College Of Wisconsin · R01 · FY2004 · GM

ROLE OF B.FRAGILIS OXYGEN STRESS RESPONSE IN INFECTION

$270,231
Charles J. Smith · East Carolina University · R01 · FY2007 · AI

Structure and Function of Hexapeptide Acyltransferases

$270,213
Steven L Roderick · Albert Einstein College Of Medicine · R01 · FY2008 · AI

Development of a cell-based HTS for compounds with activity against tuberculosis

$270,139
David G Russell · Cornell University · R01 · FY2010 · AI